4
Changes in Ownership
Twist Bioscience Corp Filed Acc 0001214659-26-010968
Chief Executive Officer sold 41,570 shares at an average $151.98 ($6,317,760)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
Leproust Emily M. · Chief Executive Officer
Table I: Non-derivative
5 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2026-08-25 | Sale : show line 1 in the form 10b5-1 | −12,648 | $150.56 | $1,904,333 | 799,651 | D |
| 2026-08-25 | Sale : show line 2 in the form 10b5-1 | −12,236 | $151.36 | $1,851,980 | 787,415 | D |
| 2026-08-25 | Sale : show line 3 in the form 10b5-1 | −6,412 | $152.75 | $979,433 | 781,003 | D |
| 2026-08-25 | Sale : show line 4 in the form 10b5-1 | −9,181 | $153.93 | $1,413,204 | 771,822 | D |
| 2026-08-25 | Sale : show line 5 in the form 10b5-1 | −1,093 | $154.45 | $168,809 | 770,729 | D |
| Open-market sales · 41,570 sh · avg $151.98 · $6,317,760 | ||||||
Loading xslF345X06/marketforms-73903.xml…